-
CRISPR gene editing stocks fall after Editas CEO resigns
pharmaphorum
January 24, 2019
Shares in firms developing therapies based on CRISPR gene editing technology have fallen after the resignation of the CEO of one of the leading biotechs in the field, Editas.
-
Shkreli in the stocks is still sharing biotech tips
fiercebiotech
July 09, 2018
If you thought we wouldn't be hearing from Martin Shkreli after he was packed off to serve seven years for securities fraud, think again.
-
6 Promising Biopharmas With Major Catalysts in 2018
biospace
January 30, 2018
Not only is the biopharma market expected to be a hot one for mergers and acquisitions this year, but it’s expected to be hot for stocks as well.
-
3 Biotechs That Have Doubled Investors' Money in Less Than a Year
biospace
January 24, 2018
Having a stock double in value is a good thing. Having it double—or more—in a year is even better. Keith Speights, writing for The Motley Fool, looks at three healthcare stocks that have doubled in less than 12 months.
-
Top 5 Biotech Stocks Appear Vulnerable in 2018
biospace
January 10, 2018
Although the stock market seems to be moving up at the beginning of this year, the U.S. equities market appears more mixed, with healthcare stocks in particular appearing more volatile.
-
What are the Top 5 Biotech Stocks to Buy in 2018?
biospace
December 22, 2017
A new report by RBC provides background on the top biotech stock picks for 2018